A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/30/2013 |
| Start Date: | March 2013 |
| End Date: | March 2015 |
| Contact: | Dana Washburn, M.D. |
| Email: | dana.washburn@lantheus.com |
| Phone: | 978-671-8686 |
An Open-Label Prospective, Non-Randomized, International, Multi-center, Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) in Patients Suspected of Coronary Artery Disease (CAD)
This long-term study will follow patients with known or suspected of having coronary artery
disease (CAD) and have participated in present and future BMS747158 clinical studies. The
purpose of this study is to evaluate the long-term predictive value associated with
BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI).
Inclusion Criteria:
- Have known or suspected CAD
- Have participated in a BMS747158 clinical study
- Have received at least 1 dose of BMS747158
- Provide signed informed consent for this study prior to any follow-up contact
- Be capable of communicating effectively with study personnel
Exclusion Criteria:
- If determined by the Investigator that participation in the study is not in the best
interest of the patient or for any sound medical, psychiatric, and/or social reason.
We found this trial at
1
site
Click here to add this to my saved trials
